Two Group B Streptococcal molecular quality controls added to growing ZeptoMetrix CE/IVD offerings
ZeptoMetrix™ Corporation (ZMC) announced today the release of 2 additional CE/IVD marked molecular quality controls to its expanding CE/IVD product inventory.
“We are pleased today to introduce two Group B Streptococcal molecular quality controls to our expanding CE/IVD QC offerings. ZeptoMetrix remains entirely committed to fully support and provide our diagnostics industry with as many precise and dependable, non-infectious tools as we can to assist with accurate and reliable QC”, explains Shawn Smith, President and CEO of ZeptoMetrix.
Dedicated to strengthening its CE/IVD core, ZeptoMetrix has utilized its patented NATtrol™ inactivation treatment to provide following GBS CE/IVD molecular quality controls:
Together, the routine and repetitive use of NATtrol™ External Run Controls and Range Verification Panels enables laboratories to verify test performance, track and monitor daily test variation, lot-to-lot test kit performance and individual operator performance to provide assistance identifying trends in laboratory results.
Additional, ZeptoMetrix CE/IVD and IVD products include:
NATtrol RP Multimarker Control Pack #MDZ001
NATtrol Chlamydia trachomatis Positive Control Pack #MDZ002
NATtrol Neisseria gonorrhoeae Positive Control Pack #MDZ003
NATtrol CT/NG Negative Control Pack #MDZ004
NATtrol Clostridium difficile Positive Control #MDZ040
NATtrol Clostridium difficile Negative Control #MDZ041
NATtrol Influenza/RSV Negative Control #MDZ045
NATtrol Influenza A/B Positive Control #MDZ046
NATtrol RSV Positive Control #MDZ047
NATtrol EV Positive Control #MDZ055
NATtrol EV Negative Control #MDZ056
NATtrol MRSA Positive Control #MDZ059
NATtrol MRSA/SA Negative Control #MDZ060
NATtrol SA Positive Control #MDZ061